LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea · Delayed Price · Currency is KRW

95,400

+7,900 (9.03%)

Aug 3, 2026, 3:30 PM KST

-25.00% (1Y)

Market Cap	3.52T -23.8%
Revenue (ttm)	125.87B -14.0%
Net Income	-138.08B
EPS	-3,791.57
Shares Out	36.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	360,233
Open	85,500
Previous Close	87,500
Day's Range	84,900 - 99,300
52-Week Range	76,900 - 225,000
Beta	0.49
Analysts	Buy
Price Target	221,666.67 (+132.36%)
Earnings Date	Aug 14, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Employees 190

Stock Exchange KOSDAQ

Ticker Symbol 141080

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 141080 stock is "Buy." The 12-month stock price target is ₩221,667, which is an increase of 132.36% from the latest price.

Price Target

₩221,667

(132.36% upside)

Analyst Consensus: Buy

Stock Forecasts